Repatriation Medical Authority - Declaration - Malignant Neoplasm of the Lung

Administered by Department of Veterans' Affairs

Legislation au C2020G00223 In force Gazette

Legislation content

 

DECLARATION UNDER SUBSECTION 196B(9)

OF THE VETERANS’ ENTITLEMENTS ACT 1986

The Repatriation Medical Authority (the Authority), under subsection 196B(9) of the Veterans' Entitlements Act 1986 (the Act), makes the following declaration in respect of the review of the contents of the Statements of Principles in force under the Act concerning malignant neoplasm of the lung, Instrument Nos. 92 and 93 of 2014. 

The investigation related to "insecticides". The Notice of Investigation was published in the Government Notices Gazette of 29 October 2019.

Following the investigation, the Authority declares that it does not propose to amend Statement of Principles, Instrument No. 93 of 2014, to include factors relating to exposure to insecticides.  The reason is that the sound medical-scientific evidence available to the Authority, including the new sound medical-scientific evidence, cannot, on the balance of probabilities, connect malignant neoplasm of the lung with exposure to insecticides related to the circumstances of the relevant service referred to in subsection 196B(3) of the Act. That sound medical-scientific evidence is not sufficient to justify an amendment to the Statement of Principles, No. 93 of 2014, already determined in respect of malignant neoplasm of the lung, to include factors relating to exposure to insecticides.

The Authority proposes to determine an amendment to Statement of Principles, Instrument No. 92 of 2014, concerning malignant neoplasm of the lung, to include a factor relating to exposure to the insecticide diazinon. The Authority is of the view that the sound medical-scientific evidence available to it, including the new sound medical-scientific evidence, raises a reasonable hypothesis connecting malignant neoplasm of the lung with exposure to diazinon related to the circumstances of relevant service referred to in subsection 196B(2) of the Act. That sound medical-scientific evidence justifies an amendment of the Statement of Principles, Instrument No. 92 of 2014, concerning malignant neoplasm of the lung, to include a factor relating to exposure to diazinon.

 

 

The Common Seal of the  )

Repatriation Medical Authority )

was affixed at the direction of: )

 

PROFESSOR NICHOLAS SAUNDERS AO CHAIRPERSON  28 / 2 / 2020

 

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.